Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer

Por Shinchi, H, Maemura, K, Noma, H, Mataki, Y, Aikou, T, Takao, S
Publicado em 2007

The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma

Por Okumura, H, Natsugoe, S, Matsumoto, M, Mataki, Y, Takatori, H, Ishigami, S, Takao, S, Aikou, T
Publicado em 2005

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

Por Maeda, S, Shinchi, H, Kurahara, H, Mataki, Y, Maemura, K, Sato, M, Natsugoe, S, Aikou, T, Takao, S
Publicado em 2008

Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer

Por Arigami, T, Natsugoe, S, Uenosono, Y, Arima, H, Mataki, Y, Ehi, K, Yanagida, S, Ishigami, S, Hokita, S, Aikou, T
Publicado em 2005

Clinical significance of midkine expression in pancreatic head carcinoma

Por Maeda, S, Shinchi, H, Kurahara, H, Mataki, Y, Noma, H, Maemura, K, Aridome, K, Yokomine, T, Natsugoe, S, Aikou, T, Takao, S
Publicado em 2007